Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
CATALOGO DEI PRODOTTI DELLA RICERCA
non disponibile
Taste buds and solitary chemoreceptor cells (SCCs) in the oral cavity, larynx and nasopharynx must
both monitor potential foods as well as guard against intake of toxic materials into the alimentary
and respiratory passageways. All of these sensory cells utilize TR receptors to initiate a signaling
cascade, which utilizes TrpM5 as a requisite downstream element. Accordingly, TrpM5 is a useful
marker of likely chemoreceptor cells whether they are in taste buds or SCCs. To understand the role
of these cells, we set out to determine which taste signal transduction elements they express. For
sweet and umami, the taste signaling cascade is initiated in the taste receptor cells (TRCs) by
activation T1R receptors (good markers of chemoreceptors responsive to appetitive qualities), and
for bitter and sour, the taste signalling cascade is initiated in the TRCs by activation T2R receptors
and PKD2L1/2 candidate receptors (good markers of chemoreceptors responsive against to intake
of toxic compounds). The downstream elements for sweet, umami and bitter taste include a-
gustducin, PLCb2, IP3R3 and Trpm5. I utilized in situ hybridization, RT-PCR, two lines of
transgenic mice, TrpM5-GFP and T1R3-GFP, immunoblotting and immunohistochemistry, to
assess the distribution within the oropharynx and respiratory tract, of solitary and taste buds
chemoreceptor cells expressing these different markers. TrpM5-GFP receptor cells occur within all
taste buds, including those on the epiglottis and larynx. In addition, numerous, scattered TrpM5-
GFP SCCs lie within the nasopharynx, larynx and trachea. a-gustducin, PLCb2 and Trpm5 are
expressed in taste buds cells of the oropharynx as well as SCCs throughout the epiglottis,
oropharynx, larynx and trachea of mice, rat and bovine. By RT-PCR studies on rats, T1Rs receptors
were localized predominantly in lingual, palatal and laryngeal tissue. Comparatively, T1R3-GFP
cells occur predominantly in lingual and palatal taste buds, few T1R3-GFP cells are present in
laryngeal taste buds and essentially no T1R3-positive SCCs are present within the airways. These
results from transgenic mice T1R3-GFP are largely confirmed by in situ hybridization studies on rat
T1Rs: laryngeal taste buds exhibit low expression of T1Rs compared to lingual and palatal taste
buds, and no T1Rs-positive SCCs are present within the airways. Thus, it seems that laryngeal taste
buds and SCCs do not display molecular features associated with detection of sweet or umami
compounds. By RT-PCR studies on rats, bitter and sour receptors occur either in lingual, palatal,
nasal and laryngeal tissue, but only T2Rs were present in trachea and bronchi. Thus, it seems that
T2Rs play an important role as guard against intake of toxic materials and in the protective
chemoreflex of respiratory passageways. These findings are consistent with electrophysiological
studies on the superior laryngeal nerve (188), showing minimal responsiveness to sweet and umami
substances, but large responses to bitter and sour-tasting stimuli.
Moreover, by gene microarray experiments, I demonstrate that the action of AHLs, quorum sensing
gram negative bacterial pheromones, is not only limited to activate conspecific bacteria, but also
modify innate defence mechanisms of the airway. AHLs induce an early mucosal response related
to the length of their acylic chain. The chondrioma of ciliate and secretory cells is the main
cytological target of AHL action. However, the airways present a population of cells, the SCCs, that
resists to the AHL-induced lesion. An important question is if some of the responses detected after
treatment with AHL are part of a defensive mechanism operated by the mucosa. This might be the
case of the secretory response elicited by C12-HSL. It is possible to speculate that the increased
secretion could dilute the bacterial infochemicals, blocking the quorum sensing based strategy. In
the response of the airway to AHL, the most interesting new finding is the high resistance of the
SCCs, which do not display the mitochondrial alterations detectable in ciliate or secretory elements.
The SCCs are a part of a diffuse chemosensory system (DCS) that control the whole airway, and are
located in ideal positions to evaluate the mucus composition into the airways or the presence of
infochemicals generated by resident micro-organisms. Recent studies demonstrated that SCCs are
sentinels active against irritants (105). These data suggest that SCCs could have a role in bacterial
infections, because ultrastructural analysis demonstrated that they are activated by AHL.
Considering the chemoreceptorial capability of SCCs, it seems probable that they have a role in
innate mechanism of defences that operates in presence of bacterial infochemicals. In conclusion, if
the main taste system plays a role in food sampling, the DCS seems rather to be an alarm system. In
the respiratory apparatus it could provide information about the luminal microenvironment. The
DCS is probably the afferent branch of intrinsic mechanisms, which might involve gland secretion
and muscle contraction. Local reflexes could be generated by interaction between the DCS and
surrounding elements. The transmission of information from the DCS to the central nervous system
is possible, but appears to be limited to the chemosensory cells innervated by afferent axons. Such
cells seem to be a minority and are mainly localized in the larynx. For the elements not innervated,
a paracrine action seems probable. Finally, the DCS seems to be a potential new drug target because
several elements indicate that information obtained by this system induces secretory reflexes.
Therefore, modulation of the respiratory apparatus by substances acting on their chemoreceptors
could be important in the treatment of diseases such as cystic fibrosis and asthma, and might open a
new frontier in drug discovery.
Finally, by RT-PCR studies on humans and rats, I showed that a new form of P5CDh enzyme,
involved in proline catabolism, exist in rat liver. LRRP Ba1-651 is probably a Delta-1-pyrroline-5-
carboxylate dehydrogenase, fused with the extramembrane receptor domain of sweet receptor
T1R2, activated by changes in the concentration of sweet molecules. After partial epatectomy,
constitutive P5CDh and inducible P5CDh-T1R2 co-exist in rat liver tissue. This finding
demonstrates as part of a taste receptor sequence, the receptor domain, could be used for a
completely different function and in no taste organs. Type II hyperprolinemia (HPII) is an inborn
error of metabolism due to a deficiency of P5CDh enzyme, thus it will be very interesting and
important carry out further studies that contribute to understand the biological significance of this
P5CDh-ANF enzyme, especially for the potential applications in the treatment of HPII, other liver
diseases and in liver transplantation.
Taste buds and solitary chemoreceptor cells (SCCs) in the oral cavity, larynx and nasopharynx must
both monitor potential foods as well as guard against intake of toxic materials into the alimentary
and respiratory passageways. All of these sensory cells utilize TR receptors to initiate a signaling
cascade, which utilizes TrpM5 as a requisite downstream element. Accordingly, TrpM5 is a useful
marker of likely chemoreceptor cells whether they are in taste buds or SCCs. To understand the role
of these cells, we set out to determine which taste signal transduction elements they express. For
sweet and umami, the taste signaling cascade is initiated in the taste receptor cells (TRCs) by
activation T1R receptors (good markers of chemoreceptors responsive to appetitive qualities), and
for bitter and sour, the taste signalling cascade is initiated in the TRCs by activation T2R receptors
and PKD2L1/2 candidate receptors (good markers of chemoreceptors responsive against to intake
of toxic compounds). The downstream elements for sweet, umami and bitter taste include a-
gustducin, PLCb2, IP3R3 and Trpm5. I utilized in situ hybridization, RT-PCR, two lines of
transgenic mice, TrpM5-GFP and T1R3-GFP, immunoblotting and immunohistochemistry, to
assess the distribution within the oropharynx and respiratory tract, of solitary and taste buds
chemoreceptor cells expressing these different markers. TrpM5-GFP receptor cells occur within all
taste buds, including those on the epiglottis and larynx. In addition, numerous, scattered TrpM5-
GFP SCCs lie within the nasopharynx, larynx and trachea. a-gustducin, PLCb2 and Trpm5 are
expressed in taste buds cells of the oropharynx as well as SCCs throughout the epiglottis,
oropharynx, larynx and trachea of mice, rat and bovine. By RT-PCR studies on rats, T1Rs receptors
were localized predominantly in lingual, palatal and laryngeal tissue. Comparatively, T1R3-GFP
cells occur predominantly in lingual and palatal taste buds, few T1R3-GFP cells are present in
laryngeal taste buds and essentially no T1R3-positive SCCs are present within the airways. These
results from transgenic mice T1R3-GFP are largely confirmed by in situ hybridization studies on rat
T1Rs: laryngeal taste buds exhibit low expression of T1Rs compared to lingual and palatal taste
buds, and no T1Rs-positive SCCs are present within the airways. Thus, it seems that laryngeal taste
buds and SCCs do not display molecular features associated with detection of sweet or umami
compounds. By RT-PCR studies on rats, bitter and sour receptors occur either in lingual, palatal,
nasal and laryngeal tissue, but only T2Rs were present in trachea and bronchi. Thus, it seems that
T2Rs play an important role as guard against intake of toxic materials and in the protective
chemoreflex of respiratory passageways. These findings are consistent with electrophysiological
studies on the superior laryngeal nerve (188), showing minimal responsiveness to sweet and umami
substances, but large responses to bitter and sour-tasting stimuli.
Moreover, by gene microarray experiments, I demonstrate that the action of AHLs, quorum sensing
gram negative bacterial pheromones, is not only limited to activate conspecific bacteria, but also
modify innate defence mechanisms of the airway. AHLs induce an early mucosal response related
to the length of their acylic chain. The chondrioma of ciliate and secretory cells is the main
cytological target of AHL action. However, the airways present a population of cells, the SCCs, that
resists to the AHL-induced lesion. An important question is if some of the responses detected after
treatment with AHL are part of a defensive mechanism operated by the mucosa. This might be the
case of the secretory response elicited by C12-HSL. It is possible to speculate that the increased
secretion could dilute the bacterial infochemicals, blocking the quorum sensing based strategy. In
the response of the airway to AHL, the most interesting new finding is the high resistance of the
SCCs, which do not display the mitochondrial alterations detectable in ciliate or secretory elements.
The SCCs are a part of a diffuse chemosensory system (DCS) that control the whole airway, and are
located in ideal positions to evaluate the mucus composition into the airways or the presence of
infochemicals generated by resident micro-organisms. Recent studies demonstrated that SCCs are
sentinels active against irritants (105). These data suggest that SCCs could have a role in bacterial
infections, because ultrastructural analysis demonstrated that they are activated by AHL.
Considering the chemoreceptorial capability of SCCs, it seems probable that they have a role in
innate mechanism of defences that operates in presence of bacterial infochemicals. In conclusion, if
the main taste system plays a role in food sampling, the DCS seems rather to be an alarm system. In
the respiratory apparatus it could provide information about the luminal microenvironment. The
DCS is probably the afferent branch of intrinsic mechanisms, which might involve gland secretion
and muscle contraction. Local reflexes could be generated by interaction between the DCS and
surrounding elements. The transmission of information from the DCS to the central nervous system
is possible, but appears to be limited to the chemosensory cells innervated by afferent axons. Such
cells seem to be a minority and are mainly localized in the larynx. For the elements not innervated,
a paracrine action seems probable. Finally, the DCS seems to be a potential new drug target because
several elements indicate that information obtained by this system induces secretory reflexes.
Therefore, modulation of the respiratory apparatus by substances acting on their chemoreceptors
could be important in the treatment of diseases such as cystic fibrosis and asthma, and might open a
new frontier in drug discovery.
Finally, by RT-PCR studies on humans and rats, I showed that a new form of P5CDh enzyme,
involved in proline catabolism, exist in rat liver. LRRP Ba1-651 is probably a Delta-1-pyrroline-5-
carboxylate dehydrogenase, fused with the extramembrane receptor domain of sweet receptor
T1R2, activated by changes in the concentration of sweet molecules. After partial epatectomy,
constitutive P5CDh and inducible P5CDh-T1R2 co-exist in rat liver tissue. This finding
demonstrates as part of a taste receptor sequence, the receptor domain, could be used for a
completely different function and in no taste organs. Type II hyperprolinemia (HPII) is an inborn
error of metabolism due to a deficiency of P5CDh enzyme, thus it will be very interesting and
important carry out further studies that contribute to understand the biological significance of this
P5CDh-ANF enzyme, especially for the potential applications in the treatment of HPII, other liver
diseases and in liver transplantation.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/337782
Citazioni
ND
ND
ND
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
Il report seguente simula gli indicatori relativi alla propria produzione scientifica in relazione alle soglie ASN 2021-2023 del proprio SC/SSD. Si ricorda che il superamento dei valori soglia (almeno 2 su 3) è requisito necessario ma non sufficiente al conseguimento dell'abilitazione. La simulazione si basa sui dati IRIS e sugli indicatori bibliometrici alla data indicata e non tiene conto di eventuali periodi di congedo obbligatorio, che in sede di domanda ASN danno diritto a incrementi percentuali dei valori. La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. Si consideri che Anvur calcola i valori degli indicatori all'ultima data utile per la presentazione delle domande.
La presente simulazione è stata realizzata sulla base delle specifiche raccolte sul tavolo ER del Focus Group IRIS coordinato dall’Università di Modena e Reggio Emilia e delle regole riportate nel DM 589/2018 e allegata Tabella A. Cineca, l’Università di Modena e Reggio Emilia e il Focus Group IRIS non si assumono alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione. Si specifica inoltre che la simulazione contiene calcoli effettuati con dati e algoritmi di pubblico dominio e deve quindi essere considerata come un mero ausilio al calcolo svolgibile manualmente o con strumenti equivalenti.